CFA
BCRX icon

Cahill Financial Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

Cahill Financial Advisors’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,300
Closed -$47K – 277
2021
Q3 		$47K Buy
+3,300
New +$47K 0.01% 345